The company, which produces and distributes more than 140 pharmaceutical treatments, will implement elements of the Oracle E-Business Suite 11i, as well as the Oracle technology platform for its in-house application development needs.
In selecting the Oracle E-Business Suite, Sedico now has the capability to centrally procure the raw materials for its pharmaceuticals, while creating recipe-based, optimized manufacturing operations that improve both cost-effectiveness and quality assurance. Sedico is also using tools such as Oracle Financials Intelligence, Oracle Manufacturing Intelligence, and Oracle Financial & Sales Analyser, to monitor its cashflow and improve the efficiency of its processes.
“The pharmaceutical sector is incredibly competitive, and one of the ways that Sedico can support the Middle East’s manufacturing sector is to ensure that our treatments are sourced, manufactured, and sold to a world-class standard,” said Mamdouh Attia, Sedico’s Financial Controller.
“Centralizing all of our manufacturing, financial and sales information will improve Sedico’s internal decision-making process, and keep us better informed about the types of new treatments that consumers want, and how they can be cost-effectively manufactured, making us a more agile and market-aware organization,” he said.
From a technology perspective, Sedico’s Oracle business applications can be seamlessly integrated with the solutions that the company develops in-house using the Oracle9i Developer Suite. The single data model and unified platform delivered by Oracle mean that Sedico’s information becomes more available and secure across the entire company, without the need for costly and time-consuming integration. Oracle Middle East’s consulting services group implemented the Sedico project, Said Atef Helmy Managing Director of Oracle Egypt
“Some of the primary reasons that we selected Oracle include the breadth and competency of their regional operations, and Sedico’s conviction that Oracle’s solutions can improve the overall business performance of our company,” added Helmy
Monday, April 12- 2004 @ 11:57 UAE local time (GMT+4) Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of Mediaquest FZ LLC.